|
1
|
Valastyan S and Weinberg RA: Tumor
metastasis: Molecular insights and evolving paradigms. Cell.
147:275–292. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Han Y, Wang D, Peng L, Huang T, He X, Wang
J and Ou C: Single-cell sequencing: A promising approach for
uncovering the mechanisms of tumor metastasis. J Hematol Oncol.
15:592022. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zhou H, He X, He Y, Ou C and Cao P:
Exosomal circRNAs: Emerging players in tumor metastasis. Front Cell
Dev Biol. 9:7862242021. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Liao Z, Nie H, Wang Y, Luo J, Zhou J and
Ou C: The emerging landscape of long non-coding RNAs in colorectal
cancer metastasis. Front Oncol. 11:6413432021. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Li Y, Liu F, Cai Q, Deng L, Ouyang Q,
Zhang XH and Zheng J: Invasion and metastasis in cancer: Molecular
insights and therapeutic targets. Signal Transduct Target Ther.
10:572025. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Francoeur AA, Monk BJ and Tewari KS:
Treatment advances across the cervical cancer spectrum. Nat Rev
Clin Oncol. 22:182–199. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kaur R, Bhardwaj A and Gupta S: Cancer
treatment therapies: Traditional to modern approaches to combat
cancers. Mol Biol Rep. 50:9663–9676. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Klein CA: Cancer progression and the
invisible phase of metastatic colonization. Nat Rev Cancer.
20:681–694. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Gerstberger S, Jiang Q and Ganesh K:
Metastasis. Cell. 186:1564–1579. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Johan MZ and Samuel MS: Rho-ROCK signaling
regulates tumor-microenvironment interactions. Biochem Soc Trans.
47:101–108. 2019. View Article : Google Scholar
|
|
12
|
Hall A: Rho family GTPases. Biochem Soc
Trans. 40:1378–1382. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Etienne-Manneville S and Hall A: Rho
GTPases in cell biology. Nature. 420:629–635. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liu C, Chen S, Zhang Y, Zhou X, Wang H,
Wang Q and Lan X: Mechanisms of Rho GTPases in regulating tumor
proliferation, migration and invasion. Cytokine Growth Factor Rev.
80:168–174. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Alarcon VB and Marikawa Y: Trophectoderm
formation: Regulation of morphogenesis and gene expressions by RHO,
ROCK, cell polarity, and HIPPO signaling. Reproduction.
164:R75–R86. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Agrawal A, Scott ZC and Koslover EF:
Morphology and transport in eukaryotic cells. Annu Rev Biophys.
51:247–266. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ando D, Korabel N, Huang KC and Gopinathan
A: Cytoskeletal network morphology regulates intracellular
transport dynamics. Biophys J. 109:1574–1582. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Fletcher DA and Mullins RD: Cell mechanics
and the cytoskeleton. Nature. 463:485–492. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Park J, Wu Y, Kim JS, Byun J, Lee J and Oh
YK: Cytoskeleton-modulating nanomaterials and their therapeutic
potentials. Adv Drug Deliv Rev. 211:1153622024. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Leduc C and Etienne-Manneville S:
Intermediate filaments in cell migration and invasion: The unusual
suspects. Curr Opin Cell Biol. 32:102–112. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Li M, Peng L, Wang Z, Liu L, Cao M, Cui J,
Wu F and Yang J: Roles of the cytoskeleton in human diseases. Mol
Biol Rep. 50:2847–2856. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Thapa N, Wen T, Cryns VL and Anderson RA:
Regulation of cell adhesion and migration via microtubule
cytoskeleton organization, cell polarity, and phosphoinositide
signaling. Biomolecules. 13:14302023. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Mangaonkar S, Nath S and Chatterji BP:
Microtubule dynamics in cancer metastasis: Harnessing the
underappreciated potential for therapeutic interventions. Pharmacol
Ther. 263:1087262024. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Fanale D, Bronte G, Passiglia F, Calò V,
Castiglia M, Di Piazza F, Barraco N, Cangemi A, Catarella MT,
Insalaco L, et al: Stabilizing versus destabilizing the
microtubules: A double-edge sword for an effective cancer treatment
option? Anal Cell Pathol (Amst). 2015:6909162015.PubMed/NCBI
|
|
25
|
Dumontet C, Reichert JM, Senter PD,
Lambert JM and Beck A: Antibody-drug conjugates come of age in
oncology. Nat Rev Drug Discov. 22:641–661. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Cai J, He M, Wang Y, Zhang H, Xu Y, Wang
Y, You C and Gao H: Discovery of a novel microtubule destabilizing
agent targeting the colchicine site based on molecular docking.
Biochem Pharmacol. 234:1168042025. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Castaldo V, Minopoli M, Di Modugno F,
Sacconi A, Liguoro D, Frigerio R, Ortolano A, Di Martile M,
Gesualdi L, Madonna G, et al: Upregulated expression of miR-4443
and miR-4488 in drug resistant melanomas promotes migratory and
invasive phenotypes through downregulation of intermediate filament
nestin. J Exp Clin Cancer Res. 42:3172023. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ishiwata T, Matsuda Y and Naito Z: Nestin
in gastrointestinal and other cancers: Effects on cells and tumor
angiogenesis. World J Gastroenterol. 17:409–418. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Atianand MK, Caffrey DR and Fitzgerald KA:
Immunobiology of long noncoding RNAs. Annu Rev Immunol. 35:177–198.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wang D, Han Y, Peng L, Huang T, He X, Wang
J and Ou C: Crosstalk between N6-methyladenosine (m6A) modification
and noncoding RNA in tumor microenvironment. Int J Biol Sci.
19:2198–2219. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ou C, Sun Z, He X, Li X, Fan S, Zheng X,
Peng Q, Li G, Li X and Ma J: Targeting YAP1/LINC00152/FSCN1
signaling axis prevents the progression of colorectal cancer. Adv
Sci (Weinh). 7:19013802020. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
He X, Yu B, Kuang G, Wu Y, Zhang M, Cao P
and Ou C: Long noncoding RNA DLEU2 affects the proliferative and
invasive ability of colorectal cancer cells. J Cancer. 12:428–437.
2021. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Chan JJ and Tay Y: Noncoding RNA:RNA
regulatory networks in cancer. Int J Mol Sci. 19:13102018.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Yan H and Bu P: Non-coding RNA in cancer.
Essays Biochem. 65:625–639. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Chen LL and Kim VN: Small and long
non-coding RNAs: Past, present, and future. Cell. 187:6451–6485.
2024. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Nadhan R, Isidoro C, Song YS and
Dhanasekaran DN: Signaling by LncRNAs: Structure, cellular
homeostasis, and disease pathology. Cells. 11:25172022. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Mohammad F, Mondal T and Kanduri C:
Epigenetics of imprinted long noncoding RNAs. Epigenetics.
4:277–286. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Heo JB and Sung S: Vernalization-mediated
epigenetic silencing by a long intronic noncoding RNA. Science.
331:76–79. 2011. View Article : Google Scholar
|
|
39
|
Good MC, Zalatan JG and Lim WA: Scaffold
proteins: Hubs for controlling the flow of cellular information.
Science. 332:680–686. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Spitale RC, Tsai MC and Chang HY: RNA
templating the epigenome: Long noncoding RNAs as molecular
scaffolds. Epigenetics. 6:539–543. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Zhao W, Song M, Zhang J, Kuerban M and
Wang H: Combined identification of long non-coding RNA CCAT1 and
HOTAIR in serum as an effective screening for colorectal carcinoma.
Int J Clin Exp Pathol. 8:14131–14140. 2015.
|
|
42
|
Shao Y, Ye M, Jiang X, Sun W, Ding X, Liu
Z, Ye G, Zhang X, Xiao B and Guo J: Gastric juice long noncoding
RNA used as a tumor marker for screening gastric cancer. Cancer.
120:3320–3328. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Li J, Wang X, Tang J, Jiang R, Zhang W, Ji
J and Sun B: HULC and Linc00152 act as novel biomarkers in
predicting diagnosis of hepatocellular carcinoma. Cell Physiol
Biochem. 37:687–696. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Tong YS, Wang XW, Zhou XL, Liu ZH, Yang
TX, Shi WH, Xie HW, Lv J, Wu QQ and Cao XF: Identification of the
long non-coding RNA POU3F3 in plasma as a novel biomarker for
diagnosis of esophageal squamous cell carcinoma. Mol Cancer.
14:32015. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Jiang YZ, Liu YR, Xu XE, Jin X, Hu X, Yu
KD and Shao ZM: Transcriptome analysis of triple-negative breast
cancer reveals an integrated mRNA-lncRNA signature with predictive
and prognostic value. Cancer Res. 76:2105–2114. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Shen L, Chen L, Wang Y, Jiang X, Xia H and
Zhuang Z: Long noncoding RNA MALAT1 promotes brain metastasis by
inducing epithelial-mesenchymal transition in lung cancer. J
Neurooncol. 121:101–108. 2015. View Article : Google Scholar
|
|
47
|
Yu W, Ma Y, Hou W, Wang F, Cheng W, Qiu F,
Wu P and Zhang G: Identification of immune-related lncRNA
prognostic signature and molecular subtypes for glioblastoma. Front
Immunol. 12:7069362021. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Kong X, Qi J, Yan Y, Chen L, Zhao Y, Fang
Z, Fan J, Liu M and Liu Y: Comprehensive analysis of differentially
expressed profiles of lncRNAs, mRNAs, and miRNAs in laryngeal
squamous cell carcinoma in order to construct a ceRNA network and
identify potential biomarkers. J Cell Biochem. 120:17963–17974.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Jing Z, Guo S, Zhang P and Liang Z:
LncRNA-Associated ceRNA network reveals novel potential biomarkers
of laryngeal squamous cell carcinoma. Technol Cancer Res Treat.
19:15330338209857872020. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Zhang H, Zhang N, Wu W, Zhou R, Li S, Wang
Z, Dai Z, Zhang L, Liu Z, Zhang J, et al: Machine learning-based
tumor-infiltrating immune cell-associated lncRNAs for predicting
prognosis and immunotherapy response in patients with glioblastoma.
Brief Bioinform. 23:bbac3862022. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Nemeth K, Bayraktar R, Ferracin M and
Calin GA: Non-coding RNAs in disease: From mechanisms to
therapeutics. Nat Rev Genet. 25:211–232. 2024. View Article : Google Scholar
|
|
52
|
Fatica A and Bozzoni I: Long non-coding
RNAs: New players in cell differentiation and development. Nat Rev
Genet. 15:7–21. 2014. View Article : Google Scholar
|
|
53
|
Katayama S, Tomaru Y, Kasukawa T, Waki K,
Nakanishi M, Nakamura M, Nishida H, Yap CC, Suzuki M, Kawai J, et
al: Antisense transcription in the mammalian transcriptome.
Science. 309:1564–1566. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Bunch H, Lawney BP, Burkholder A, Ma D,
Zheng X, Motola S, Fargo DC, Levine SS, Wang YE and Hu G: RNA
polymerase II promoter-proximal pausing in mammalian long
non-coding genes. Genomics. 108:64–77. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Nojima T and Proudfoot NJ: Mechanisms of
lncRNA biogenesis as revealed by nascent transcriptomics. Nat Rev
Mol Cell Biol. 23:389–406. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Ulitsky I and Bartel DP: lincRNAs:
Genomics, evolution, and mechanisms. Cell. 154:26–46. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Collins FS, Morgan M and Patrinos A: The
human genome project: Lessons from large-scale biology. Science.
300:286–290. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Green ED, Watson JD and Collins FS: Human
genome project: Twenty-five years of big biology. Nature.
526:29–31. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Hombach S and Kretz M: Non-coding RNAs:
Classification, biology and functioning. Adv Exp Med Biol.
937:3–17. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Koffler-Brill T, Noy Y and Avraham KB: The
long and short: Non-coding RNAs in the mammalian inner ear. Hear
Res. 428:1086662023. View Article : Google Scholar :
|
|
61
|
Zhao J, Sun BK, Erwin JA, Song JJ and Lee
JT: Polycomb proteins targeted by a short repeat RNA to the mouse X
chromosome. Science. 322:750–756. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Yang F, Deng X, Ma W, Berletch JB, Rabaia
N, Wei G, Moore JM, Filippova GN, Xu J, Liu Y, et al: The lncRNA
Firre anchors the inactive X chromosome to the nucleolus by binding
CTCF and maintains H3K27me3 methylation. Genome Biol. 16:522015.
View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Martianov I, Ramadass A, Barros AS, Chow N
and Akoulitchev A: Repression of the human dihydrofolate reductase
gene by a non-coding interfering transcript. Nature. 445:666–670.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Bailey C, Pich O, Thol K, Watkins TBK,
Luebeck J, Rowan A, Stavrou G, Weiser NE, Dameracharla B, Bentham
R, et al: Origins and impact of extrachromosomal DNA. Nature.
635:193–200. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Lopez-Pajares V, Qu K, Zhang J, Webster
DE, Barajas BC, Siprashvili Z, Zarnegar BJ, Boxer LD, Rios EJ, Tao
S, et al: A LncRNA-MAF:MAFB transcription factor network regulates
epidermal differentiation. Dev Cell. 32:693–706. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Cesana M, Cacchiarelli D, Legnini I,
Santini T, Sthandier O, Chinappi M, Tramontano A and Bozzoni I: A
long noncoding RNA controls muscle differentiation by functioning
as a competing endogenous RNA. Cell. 147:358–369. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Wang Y, Xu Z, Jiang J, Xu C, Kang J, Xiao
L, Wu M, Xiong J, Guo X and Liu H: Endogenous miRNA sponge
lincRNA-RoR regulates Oct4, Nanog, and Sox2 in human embryonic stem
cell self-renewal. Dev Cell. 25:69–80. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Li X, Wu Z, Fu X and Han W: lncRNAs:
Insights into their function and mechanics in underlying disorders.
Mutat Res Rev Mutat Res. 762:1–21. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Rapicavoli NA, Qu K, Zhang J, Mikhail M,
Laberge RM and Chang HY: A mammalian pseudogene lncRNA at the
interface of inflammation and anti-inflammatory therapeutics.
Elife. 2:e007622013. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Hung T, Wang Y, Lin MF, Koegel AK, Kotake
Y, Grant GD, Horlings HM, Shah N, Umbricht C, Wang P, et al:
Extensive and coordinated transcription of noncoding RNAs within
cell-cycle promoters. Nat Genet. 43:621–629. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Loewer S, Cabili MN, Guttman M, Loh YH,
Thomas K, Park IH, Garber M, Curran M, Onder T, Agarwal S, et al:
Large intergenic non-coding RNA-RoR modulates reprogramming of
human induced pluripotent stem cells. Nat Genet. 42:1113–1117.
2010. View
Article : Google Scholar : PubMed/NCBI
|
|
72
|
Jiang M, Zhang S, Yang Z, Lin H, Zhu J,
Liu L, Wang W, Liu S, Liu W, Ma Y, et al: Self-Recognition of an
inducible host lncRNA by RIG-I feedback restricts innate immune
response. Cell. 173:906–919. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Ferrer J and Dimitrova N: Transcription
regulation by long non-coding RNAs: Mechanisms and disease
relevance. Nat Rev Mol Cell Biol. 25:396–415. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Kallen AN, Zhou XB, Xu J, Qiao C, Ma J,
Yan L, Lu L, Liu C, Yi JS, Zhang H, et al: The imprinted H19 lncRNA
antagonizes let-7 microRNAs. Mol Cell. 52:101–112. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Yang L, Froberg JE and Lee JT: Long
noncoding RNAs: Fresh perspectives into the RNA world. Trends
Biochem Sci. 39:35–43. 2014. View Article : Google Scholar :
|
|
76
|
Wu Y, Zhang L, Zhang L, Wang Y, Li H, Ren
X, Wei F, Yu W, Liu T, Wang X, et al: Long non-coding RNA HOTAIR
promotes tumor cell invasion and metastasis by recruiting EZH2 and
repressing E-cadherin in oral squamous cell carcinoma. Int J Oncol.
46:2586–2594. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Bonasio R, Tu S and Reinberg D: Molecular
signals of epigenetic states. Science. 330:612–616. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Ingolia NT, Lareau LF and Weissman JS:
Ribosome profiling of mouse embryonic stem cells reveals the
complexity and dynamics of mammalian proteomes. Cell. 147:789–802.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Zhao S, Meng J and Luan Y: LncRNA-Encoded
short peptides identification using feature subset recombination
and ensemble learning. Interdiscip Sci. 14:101–112. 2022.
View Article : Google Scholar
|
|
80
|
Zhao S, Meng J, Kang Q and Luan Y:
Identifying LncRNA-encoded short peptides using optimized hybrid
features and ensemble learning. IEEE/ACM Trans Comput Biol
Bioinform. 19:2873–2881. 2022. View Article : Google Scholar
|
|
81
|
Jiang W, Zhang X, Xu Z, Cheng Q, Li X, Zhu
Y, Lu F, Dong L, Zeng L, Zhong W, et al: High-throughput
single-nucleus RNA profiling of minimal puncture FFPE samples
reveals spatiotemporal heterogeneity of cancer. Adv Sci (Weinh).
12:e24107132025. View Article : Google Scholar
|
|
82
|
Tsai MC, Manor O, Wan Y, Mosammaparast N,
Wang JK, Lan F, Shi Y, Segal E and Chang H: Long noncoding RNA as
modular scaffold of histone modification complexes. Science.
329:689–693. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Gupta RA, Shah N, Wang KC, Kim J, Horlings
HM, Wong DJ, Tsai MC, Hung T, Argani P, Rinn JL, et al: Long
non-coding RNA HOTAIR reprograms chromatin state to promote cancer
metastasis. Nature. 464:1071–1076. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Wang BR, Chu DX, Cheng MY, Jin Y, Luo HG
and Li N: Progress of HOTAIR-microRNA in hepatocellular carcinoma.
Hered Cancer Clin Pract. 20:42022. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Zhang J, Luo Q, Li X, Guo J, Zhu Q, Lu X,
Wei L, Xiang Z, Peng M, Ou C and Zou Y: Novel role of
immune-related non-coding RNAs as potential biomarkers regulating
tumour immunoresponse via MICA/NKG2D pathway. Biomark Res.
11:862023. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Zhou M, He X, Mei C and Ou C: Exosome
derived from tumor-associated macrophages: Biogenesis, functions,
and therapeutic implications in human cancers. Biomark Res.
11:1002023. View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Zhang R, Xia Y, Wang Z, Zheng J, Chen Y,
Li X, Wang Y and Ming H: Serum long non coding RNA MALAT-1
protected by exosomes is up-regulated and promotes cell
proliferation and migration in non-small cell lung cancer. Biochem
Biophys Res Commun. 490:406–414. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Zhang W, Wang Q, Yang Y, Zhou S, Zhang P
and Feng T: The role of exosomal lncRNAs in cancer biology and
clinical management. Exp Mol Med. 53:1669–1673. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Tao Y, Tang Y, Yang Z, Wu F, Wang L, Yang
L, Lei L, Jing Y, Jiang X, Jin H, et al: Exploration of serum
exosomal LncRNA TBILA and AGAP2-AS1 as promising biomarkers for
diagnosis of non-small cell lung cancer. Int J Biol Sci.
16:471–482. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Sun W, Jiang C, Liu Q, Wang N, Huang R,
Jiang G and Yang Y: Exosomal noncoding RNAs: Decoding their role in
thyroid cancer progression. Front Endocrinol (Lausanne).
15:13372262024. View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Hanifa M, Singh M, Randhawa PK, Jaggi AS
and Bali A: A focus on Rho/ROCK signaling pathway: An emerging
therapeutic target in depression. Eur J Pharmacol. 946:1756482023.
View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Narumiya S, Tanji M and Ishizaki T: Rho
signaling, ROCK and mDia1, in transformation, metastasis and
invasion. Cancer Metastasis Rev. 28:65–76. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Chin VT, Nagrial AM, Chou A, Biankin AV,
Gill AJ, Timpson P and Pajic M: Rho-associated kinase signalling
and the cancer microenvironment: novel biological implications and
therapeutic opportunities. Expert Rev Mol Med. 17:e172015.
View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Burridge K and Wennerberg K: Rho and Rac
take center stage. Cell. 116:167–179. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Zheng Y: Dbl family guanine nucleotide
exchange factors. Trends Biochem Sci. 26:724–732. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
96
|
Moon SY and Zheng Y: Rho GTPase-activating
proteins in cell regulation. Trends Cell Biol. 13:13–22. 2003.
View Article : Google Scholar
|
|
97
|
Jin D, Durgan J and Hall A: Functional
cross-talk between Cdc42 and two downstream targets, Par6B and
PAK4. Biochem J. 467:293–302. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
98
|
Seetharaman S and Etienne-Manneville S:
Cytoskeletal crosstalk in cell migration. Trends Cell Biol.
30:720–735. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
99
|
Navarro-Lérida I, Sánchez-Álvarez M and
Del Pozo M: Post-Translational modification and subcellular
compartmentalization: Emerging concepts on the regulation and
physiopathological relevance of RhoGTPases. Cells. 10:19902021.
View Article : Google Scholar : PubMed/NCBI
|
|
100
|
Fukata Y, Amano M and Kaibuchi K:
Rho-Rho-kinase pathway in smooth muscle contraction and
cytoskeletal reorganization of non-muscle cells. Trends Pharmacol
Sci. 22:32–39. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
101
|
Hall A: Rho GTPases and the control of
cell behaviour. Biochem Soc Trans. 33:891–895. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
102
|
Bishop AL and Hall A: Rho GTPases and
their effector proteins. Biochem J. 348:241–255. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
103
|
Ridley AJ, Paterson HF, Johnston CL,
Diekmann D and Hall A: The small GTP-binding protein rac regulates
growth factor-induced membrane ruffling. Cell. 70:401–410. 1992.
View Article : Google Scholar : PubMed/NCBI
|
|
104
|
Patel S, McKeon D, Sao K, Yang C, Naranjo
NM, Svitkina TM and Petrie RJ: Myosin II and Arp2/3 cross-talk
governs intracellular hydraulic pressure and lamellipodia
formation. Mol Biol Cell. 32:579–589. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
105
|
Eckenstaler R, Hauke M and Benndorf RA: A
current overview of RhoA, RhoB, and RhoC functions in vascular
biology and pathology. Biochem Pharmacol. 206:1153212022.
View Article : Google Scholar : PubMed/NCBI
|
|
106
|
Lou Y, Jiang Y, Liang Z, Liu B, Li T and
Zhang D: Role of RhoC in cancer cell migration. Cancer Cell Int.
21:5272021. View Article : Google Scholar : PubMed/NCBI
|
|
107
|
Steffen A, Koestler SA and Rottner K:
Requirements for and consequences of Rac-dependent protrusion. Eur
J Cell Biol. 93:184–193. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
108
|
Acevedo A and González-Billault C:
Crosstalk between Rac1-mediated actin regulation and ROS
production. Free Radic Biol Med. 116:101–113. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
109
|
Donkó A, Sharapova SO, Kabat J, Ganesan S,
Hauck FH, Bergerson JRE, Marois L, Abbott J, Moshous D, Williams
KW, et al: Clinical and functional spectrum of RAC2-related
immunodeficiency. Blood. 143:1476–1487. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
110
|
Donnelly SK, Cabrera R, Mao SPH, Christin
JR, Wu B, Guo W, Bravo-Cordero JJ, Condeelis JS, Segall JE and
Hodgson L: Rac3 regulates breast cancer invasion and metastasis by
controlling adhesion and matrix degradation. J Cell Biol.
216:4331–4349. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
111
|
He D, Xu L, Wu Y, Yuan Y, Wang Y, Liu Z,
Zhang C, Xie W, Zhang L, Geng Z, et al: Rac3, but not Rac1,
promotes ox-LDL induced endothelial dysfunction by downregulating
autophagy. J Cell Physiol. 235:1531–1542. 2020. View Article : Google Scholar
|
|
112
|
Nobes CD and Hall A: Rho, rac, and cdc42
GTPases regulate the assembly of multimolecular focal complexes
associated with actin stress fibers, lamellipodia, and filopodia.
Cell. 81:53–62. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
113
|
Nobes CD and Hall A: Rho GTPases control
polarity, protrusion, and adhesion during cell movement. J Cell
Biol. 144:1235–1244. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
114
|
Watanabe N, Madaule P, Reid T, Ishizaki T,
Watanabe G, Kakizuka A, Saito Y, Nakao K, Jockusch BM and Narumiya
S: p140mDia, a mammalian homolog of Drosophila diaphanous, is a
target protein for Rho small GTPase and is a ligand for profilin.
EMBO J. 16:3044–3056. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
115
|
Jerrell RJ and Parekh A: Matrix rigidity
differentially regulates invadopodia activity through ROCK1 and
ROCK2. Biomaterials. 84:119–129. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
116
|
Kubo T, Yamaguchi A, Iwata N and Yamashita
T: The therapeutic effects of Rho-ROCK inhibitors on CNS disorders.
Ther Clin Risk Manag. 4:605–615. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
117
|
Oka M, Fagan KA, Jones PL and McMurtry IF:
Therapeutic potential of RhoA/Rho kinase inhibitors in pulmonary
hypertension. Br J Pharmacol. 155:444–454. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
118
|
Naxerova K: Evolutionary paths towards
metastasis. Nat Rev Cancer. 25:545–560. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
119
|
Majidpoor J and Mortezaee K: Steps in
metastasis: An updated review. Med Oncol. 38:32021. View Article : Google Scholar : PubMed/NCBI
|
|
120
|
Steeg PS: Tumor metastasis: Mechanistic
insights and clinical challenges. Nat Med. 12:895–904. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
121
|
Bakir B, Chiarella AM, Pitarresi JR and
Rustgi AK: EMT, MET, plasticity, and tumor metastasis. Trends Cell
Biol. 30:764–776. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
122
|
Guo S, Huang J, Li G, Chen W, Li Z and Lei
J: The role of extracellular vesicles in circulating tumor
cell-mediated distant metastasis. Mol Cancer. 22:1932023.
View Article : Google Scholar : PubMed/NCBI
|
|
123
|
Matsuoka T and Yashiro M: Rho/ROCK
signaling in motility and metastasis of gastric cancer. World J
Gastroenterol. 20:13756–13766. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
124
|
Crosas-Molist E, Samain R, Kohlhammer L,
Orgaz JL, George SL, Maiques O, Barcelo J and Sanz-Moreno V: Rho
GTPase signaling in cancer progression and dissemination. Physiol
Rev. 102:455–510. 2022. View Article : Google Scholar
|
|
125
|
Itoh K, Yoshioka K, Akedo H, Uehata M,
Ishizaki T and Narumiya S: An essential part for Rho-associated
kinase in the transcellular invasion of tumor cells. Nat Med.
5:221–225. 1999. View
Article : Google Scholar : PubMed/NCBI
|
|
126
|
Zhang S, Tang Q, Xu F, Xue Y, Zhen Z, Deng
Y, Liu M, Chen J, Liu S, Qiu M, et al: RhoA regulates G1-S
progression of gastric cancer cells by modulation of multiple INK4
family tumor suppressors. Mol Cancer Res. 7:570–580. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
127
|
Kazmi N, Robinson T, Zheng J, Kar S,
Martin RM and Ridley AJ: Rho GTPase gene expression and breast
cancer risk: A mendelian randomization analysis. Sci Rep.
12:14632022. View Article : Google Scholar : PubMed/NCBI
|
|
128
|
Cadamuro M, Nardo G, Indraccolo S,
Dall'olmo L, Sambado L, Moserle L, Franceschet I, Colledan M,
Massani M, Stecca T, et al: Platelet-derived growth factor-D and
Rho GTPases regulate recruitment of cancer-associated fibroblasts
in cholangiocarcinoma. Hepatology. 58:1042–1053. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
129
|
Bridges MC, Daulagala AC and Kourtidis A:
LNCcation: lncRNA localization and function. J Cell Biol.
220:e2020090452021. View Article : Google Scholar : PubMed/NCBI
|
|
130
|
Nie H, Liao Z, Wang Y, Zhou J, He X and Ou
C: Exosomal long non-coding RNAs: Emerging players in cancer
metastasis and potential diagnostic biomarkers for personalized
oncology. Genes Dis. 8:769–780. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
131
|
Wang Y, Nie H, He X, Liao Z, Zhou Y, Zhou
J and Ou C: The emerging role of super enhancer-derived noncoding
RNAs in human cancer. Theranostics. 10:11049–11062. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
132
|
Kimura T, Horikoshi Y, Kuriyagawa C and
Niiyama Y: Rho/ROCK pathway and noncoding RNAs: Implications in
ischemic stroke and spinal cord injury. Int J Mol Sci.
22:115732021. View Article : Google Scholar : PubMed/NCBI
|
|
133
|
Xu X, Wang X, Geng C, Nie X and Bai C:
Long-chain non-coding RNA DAPK1 targeting miR-182 regulates
pancreatic cancer invasion and metastasis through ROCK-1/rhoa
signaling pathway. Int J Clin Exp Pathol. 10:9273–9283.
2017.PubMed/NCBI
|
|
134
|
Liu J, Zhu Y and Ge C: LncRNA ZFAS1
promotes pancreatic adenocarcinoma metastasis via the RHOA/ROCK2
pathway by sponging miR-3924. Cancer Cell Int. 20:2492020.
View Article : Google Scholar : PubMed/NCBI
|
|
135
|
Li H, Wang X, Wen C, Huo Z, Wang W, Zhan
Q, Cheng D, Chen H, Deng X, Peng C and Shen B: Long noncoding RNA
NORAD, a novel competing endogenous RNA, enhances the
hypoxia-induced epithelial-mesenchymal transition to promote
metastasis in pancreatic cancer. Mol Cancer. 16:1692017. View Article : Google Scholar : PubMed/NCBI
|
|
136
|
Liu Y, Wang Y, Fu X and Lu Z: Long
non-coding RNA NEAT1 promoted ovarian cancer cells' metastasis
through regulation of miR-382-3p/ROCK1 axial. Cancer Sci.
109:2188–2198. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
137
|
Zhao L, Ren C, Fang Y, Li P, Zhang H, Zuo
L, Zhang J and Zhao J: MiR-490-3p sponged by lncRNA NEAT1 can
attenuate lung adenocarcinoma progression by suppressing the
RhoA/ROCK signaling pathway. Ann Clin Lab Sci. 53:42–51.
2023.PubMed/NCBI
|
|
138
|
Zhang X, Wang DJ, Jia L and Zhang W:
N6-methyladenosine-mediated LINC01087 promotes lung adenocarcinoma
progression by regulating miR-514a-3p to upregulate centrosome
protein 55. Kaohsiung J Med Sci. 40:801–818. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
139
|
Wang Y, Zeng X, Wang N, Zhao W, Zhang X,
Teng S, Zhang Y and Lu Z: Long noncoding RNA DANCR, working as a
competitive endogenous RNA, promotes ROCK1-mediated proliferation
and metastasis via decoying of miR-335-5p and miR-1972 in
osteosarcoma. Mol Cancer. 17:892018. View Article : Google Scholar : PubMed/NCBI
|
|
140
|
Shao Y, Tong Z, Wei J and Yang T:
LncRNA-zinc finger protein 281 downregulates rho-associated
coiled-coil containing protein kinase 1 by upregulating miR-144 in
osteosarcoma. Oncol Lett. 20:792020. View Article : Google Scholar : PubMed/NCBI
|
|
141
|
Deng R, Zhang J and Chen J: lncRNA SNHG1
negatively regulates miRNA-101-3p to enhance the expression of
ROCK1 and promote cell proliferation, migration and invasion in
osteosarcoma. Int J Mol Med. 43:1157–1166. 2019.
|
|
142
|
Wang Z, Wang Z, Liu J and Yang H: Long
non-coding RNA SNHG5 sponges miR-26a to promote the tumorigenesis
of osteosarcoma by targeting ROCK1. Biomed Pharmacother.
107:598–605. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
143
|
Chen J, Huang X, Wang W, Xie H, Li J, Hu
Z, Zheng Z, Li H and Teng L: LncRNA CDKN2BAS predicts poor
prognosis in patients with hepatocellular carcinoma and promotes
metastasis via the miR-153-5p/ARHGAP18 signaling axis. Aging
(Albany NY). 10:3371–3381. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
144
|
Dong S, Wang W, Liao Z, Fan Y, Wang Q and
Zhang L: MYC-activated LINC00607 promotes hepatocellular carcinoma
progression by regulating the miR-584-3p/ROCK1 axis. J Gene Med.
25:e34772023. View Article : Google Scholar : PubMed/NCBI
|
|
145
|
Li R, Wan T, Qu J, Yu Y and Zheng R: Long
non-coding RNA DLEUI promotes papillary thyroid carcinoma
progression by sponging miR-421 and increasing ROCK1 expression.
Aging (Albany NY). 12:20127–20138. 2020.PubMed/NCBI
|
|
146
|
Lian Y, Xiong F, Yang L, Bo H, Gong Z,
Wang Y, Wei F, Tang Y, Li X, Liao Q, et al: Long noncoding RNA
AFAP1-AS1 acts as a competing endogenous RNA of miR-423-5p to
facilitate nasopharyngeal carcinoma metastasis through regulating
the Rho/Rac pathway. J Exp Clin Cancer Res. 37:2532018. View Article : Google Scholar : PubMed/NCBI
|
|
147
|
Feng Z, Li X, Qiu M, Luo R, Lin J and Liu
B: LncRNA EGFR-AS1 upregulates ROCK1 by sponging miR-145 to promote
esophageal squamous cell carcinoma cell invasion and migration.
Cancer Biother Radiopharm. 35:66–71. 2020.
|
|
148
|
Zhou Y, Si L, Liu Z, Shi Y and Agula B:
Long noncoding RNA zfas1 promotes progression of NSCLC via
regulating of miR-590-3p. Cell Transplant. 29:9636897209194352020.
View Article : Google Scholar : PubMed/NCBI
|
|
149
|
Song S, Bian WG, Qin Z, Zeng D, Xu JJ and
Tang HC: LncRNA BCYRN1 promotes cell migration and invasion of
non-small cell lung cancer via the miR-30b-3p/ROCK1 axis.
Neoplasma. 69:583–593. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
150
|
Yang J, Qiu Q, Qian X, Yi J, Jiao Y, Yu M,
Li X, Li J, Mi C, Zhang J, et al: Long noncoding RNA LCAT1
functions as a ceRNA to regulate RAC1 function by sponging
miR-4715-5p in lung cancer. Mol Cancer. 18:1712019. View Article : Google Scholar : PubMed/NCBI
|
|
151
|
Xiao H, Zhu Q and Zhou J: Long non-coding
RNA MALAT1 interaction with miR-429 regulates the proliferation and
EMT of lung adenocarcinoma cells through RhoA. Int J Clin Exp
Pathol. 12:419–430. 2019.
|
|
152
|
Chen K and Zhang L: LINC00339 regulates
ROCK1 by miR-152 to promote cell proliferation and migration in
hepatocellular carcinoma. J Cell Biochem. 120:14431–14443. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
153
|
Wang W, Yang T, Li D, Huang Y, Bai G and
Li Q: LINC00491 promotes cell growth and metastasis through
miR-324-5p/ROCK1 in liver cancer. J Transl Med. 19:5042021.
View Article : Google Scholar : PubMed/NCBI
|
|
154
|
You LN, Tai QW, Xu L, Hao Y, Guo WJ, Zhang
Q, Tong Q, Zhang H and Huang WK: Exosomal LINC00161 promotes
angiogenesis and metastasis via regulating miR-590-3p/ROCK axis in
hepatocellular carcinoma. Cancer Gene Ther. 28:719–736. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
155
|
Zhou Y, Fan RG, Qin CL, Jia J, Wu XD and
Zha WZ: LncRNA-H19 activates CDC42/PAK1 pathway to promote cell
proliferation, migration and invasion by targeting miR-15b in
hepatocellular carcinoma. Genomics. 111:1862–1872. 2019. View Article : Google Scholar
|
|
156
|
Guo D, Li Y, Chen Y, Zhang D, Wang X, Lu
G, Ren M, Lu X and He S: DANCR promotes HCC progression and
regulates EMT by sponging miR-27a-3p via ROCK1/LIMK1/COFILIN1
pathway. Cell Prolif. 52:e126282019. View Article : Google Scholar : PubMed/NCBI
|
|
157
|
Ma Y, Xue Y, Liu X, Qu C, Cai H, Wang P,
Li Z, Li Z and Liu Y: SNHG15 affects the growth of glioma
microvascular endothelial cells by negatively regulating miR-153.
Oncol Rep. 38:3265–3277. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
158
|
Li HL, Han PH, Pan DQ, Chen G, Lu XH and
Li J: LncRNA XIST regulates cell proliferation, migration and
invasion of glioblastoma via regulating miR-448 and ROCK1. J Biol
Regul Homeost Agents. 34:2049–2058. 2020.PubMed/NCBI
|
|
159
|
Chen X, Li D, Chen L, Hao B, Gao Y, Li L,
Zhou C, He X and Cao Y: Long noncoding RNA LINC00346 promotes
glioma cell migration, invasion and proliferation by up-regulating
ROCK1. J Cell Mol Med. 24:13010–13019. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
160
|
Wang Z, Han Y, Li Q, Wang B and Ma J:
LncRNA DLGAP1-AS1 accelerates glioblastoma cell proliferation
through targeting miR-515-5p/ROCK1/NFE2L1 axis and activating Wnt
signaling pathway. Brain Behav. 11:e23212021. View Article : Google Scholar : PubMed/NCBI
|
|
161
|
Liu Y, Gao X and Tian X: High expression
of long intergenic non-coding RNA LINC00662 contributes to
malignant growth of acute myeloid leukemia cells by upregulating
ROCK1 via sponging microRNA-340-5p. Eur J Pharmacol.
859:1725352019. View Article : Google Scholar : PubMed/NCBI
|
|
162
|
Bai H, Li X and Wu S: Up-regulation of
long non-coding RNA LOXL1-AS1 functions as an oncogene in cervical
squamous cell carcinoma by sponging miR-21. Arch Physiol Biochem.
129:143–147. 2023. View Article : Google Scholar
|
|
163
|
Chen X, Zhang Z, Ma Y, Su H, Xie P and Ran
J: LINC02381 promoted cell viability and migration via targeting
miR-133b in cervical cancer cells. Cancer Manag Res. 12:3971–3979.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
164
|
Yao X, Li X, Luo Y, Xu X, Liu J and Bu J:
LncRNA GAS5 regulates osteosarcoma cell proliferation, migration,
and invasion by regulating RHOB via sponging miR-663a. Cancer Manag
Res. 12:8253–8261. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
165
|
Wang Y, Yang T, Zhang Z, Lu M, Zhao W,
Zeng X and Zhang W: Long non-coding RNA TUG1 promotes migration and
invasion by acting as a ceRNA of miR-335-5p in osteosarcoma cells.
Cancer Sci. 108:859–867. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
166
|
Cui M, Wang J, Li Q, Zhang J, Jia J and
Zhan X: Long non-coding RNA HOXA11-AS functions as a competing
endogenous RNA to regulate ROCK1 expression by sponging miR-124-3p
in osteosarcoma. Biomed Pharmacother. 92:437–444. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
167
|
Yu X, Wang D, Wang X, Sun S, Zhang Y, Wang
S, Miao R, Xu X and Qu X: CXCL12/CXCR4 promotes inflammation-driven
colorectal cancer progression through activation of RhoA signaling
by sponging miR-133a-3p. J Exp Clin Cancer Res. 38:322019.
View Article : Google Scholar : PubMed/NCBI
|
|
168
|
Kong W, Li H, Xie L, Cui G, Gu W, Zhang H,
Ma W and Zhou Y: LncRNA MCF2L-AS1 aggravates the malignant
development of colorectal cancer via targeting miR-105-5p/RAB22A
axis. BMC Cancer. 21:10692021. View Article : Google Scholar : PubMed/NCBI
|
|
169
|
Horita K, Kurosaki H, Nakatake M, Ito M,
Kono H and Nakamura T: Long noncoding RNA UCA1 enhances sensitivity
to oncolytic vaccinia virus by sponging miR-18a/miR-182 and
modulating the Cdc42/filopodia axis in colorectal cancer. Biochem
Biophys Res Commun. 516:831–838. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
170
|
Tian Y, Zhong L, Gao S, Yu Y, Sun D, Liu
X, Ji J, Yao Y, Liu Y and Jiang Z: LncRNA LINC00974 downregulates
miR-122 to upregulate RhoA in oral squamous cell carcinoma. Cancer
Biother Radiopharm. 36:18–22. 2021.
|
|
171
|
Yang J, Wang WG and Zhang KQ: LINC00452
promotes ovarian carcinogenesis through increasing ROCK1 by
sponging miR-501-3p and suppressing ubiquitin-mediated degradation.
Aging (Albany NY). 12:21129–21146. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
172
|
Yang Q and Dong YJ: LncRNA SNHG20 promotes
migration and invasion of ovarian cancer via modulating the
microRNA-148a/ROCK1 axis. J Ovarian Res. 14:1682021. View Article : Google Scholar : PubMed/NCBI
|
|
173
|
Chen S, Wang LL, Sun KX, Xiu YL, Zong ZH,
Chen X and Zhao Y: The role of the long non-coding RNA TDRG1 in
epithelial ovarian carcinoma tumorigenesis and progression through
miR-93/RhoC pathway. Mol Carcinog. 57:225–234. 2018. View Article : Google Scholar
|
|
174
|
Liu Y, Zong ZH, Guan X, Wang LL and Zhao
Y: The role of long non-coding RNA PCA3 in epithelial ovarian
carcinoma tumorigenesis and progression. Gene. 633:42–47. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
175
|
Li HL, Wang CP, Zhang Y, Du JX, Han LH and
Yang HY: Long non-coding RNA PVT1 facilitates cell migration and
invasion by regulating miR-148a-3p and ROCK1 in breast cancer. Clin
Transl Oncol. 24:882–891. 2022. View Article : Google Scholar
|
|
176
|
Chou J, Wang B, Zheng T, Li X, Zheng L, Hu
J, Zhang Y, Xing Y and Xi T: MALAT1 induced migration and invasion
of human breast cancer cells by competitively binding miR-1 with
cdc42. Biochem Biophys Res Commun. 472:262–269. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
177
|
Chen Y, Sheng HG, Deng FM and Cai LL:
Downregulation of the long noncoding RNA SNHG1 inhibits tumor cell
migration and invasion by sponging miR-195 through targeting Cdc42
in oesophageal cancer. Kaohsiung J Med Sci. 37:181–191. 2021.
View Article : Google Scholar
|
|
178
|
Wang Z, Liu J, Wang R, Wang Q, Liang R and
Tang J: Long non-coding RNA taurine upregulated gene 1 (TUG1)
downregulation constrains cell proliferation and invasion through
regulating cell division cycle 42 (CDC42) expression Via MiR-498 in
esophageal squamous cell carcinoma cells. Med Sci Monit.
26:e9197142020.PubMed/NCBI
|
|
179
|
Zong W, Feng W, Jiang Y, Cao Y, Ke Y, Shi
X, Ju S, Cong H, Wang X, Cui M and Jing R: LncRNA CTC-497E21.4
promotes the progression of gastric cancer via modulating
miR-22/NET1 axis through RhoA signaling pathway. Gastric Cancer.
23:228–240. 2020. View Article : Google Scholar
|
|
180
|
Chen Z, Xu C, Pan X, Cheng G, Liu M, Li J
and Mei Y: lncRNA DSCR8 mediates miR-137/Cdc42 to regulate gastric
cancer cell proliferation, invasion, and cell cycle as a
competitive endogenous RNA. Mol Ther Oncolytics. 22:468–482. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
181
|
Wang J, He Z, Xu J, Chen P and Jiang J:
Long noncoding RNA LINC00941 promotes pancreatic cancer progression
by competitively binding miR-335-5p to regulate ROCK1-mediated
LIMK1/Cofilin-1 signaling. Cell Death Dis. 12:362021. View Article : Google Scholar : PubMed/NCBI
|
|
182
|
Ferrè F, Colantoni A and Helmer-Citterich
M: Revealing protein-lncRNA interaction. Brief Bioinform.
17:106–116. 2016. View Article : Google Scholar
|
|
183
|
Ren S, Zhang N, Shen L, Lu Y, Chang Y, Lin
Z, Sun N, Zhang Y, Xu J, Huang H and Jin H: Lnc00892 competes with
c-Jun to block NCL transcription, reducing the stability of
RhoA/RhoC mRNA and impairing bladder cancer invasion. Oncogene.
40:6579–6589. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
184
|
Wu Y, Shen QW, Niu YX, Chen XY, Liu HW and
Shen XY: LncNORAD interference inhibits tumor growth and lung
cancer cell proliferation, invasion and migration by
down-regulating CXCR4 to suppress RhoA/ROCK signaling pathway. Eur
Rev Med Pharmacol Sci. 24:5446–5455. 2020.PubMed/NCBI
|
|
185
|
Hu X, Xiang L, He D, Zhu R, Fang J, Wang Z
and Cao K: The long noncoding RNA KTN1-AS1 promotes bladder cancer
tumorigenesis via KTN1 cis-activation and the consequent initiation
of Rho GTPase-mediated signaling. Clin Sci (Lond). 135:555–574.
2021. View Article : Google Scholar : PubMed/NCBI
|
|
186
|
Ge Z, Cheng Z, Yang X, Huo X, Wang N, Wang
H, Wang C, Gu D, Zhao F, Yao M, et al: Long noncoding RNA SchLAH
suppresses metastasis of hepatocellular carcinoma through
interacting with fused in sarcoma. Cancer Sci. 108:653–662. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
187
|
Dai R, Zhou Y, Chen Z, Zou Z, Pan Z, Liu P
and Gao X: Lnc-MUC20-9 binds to ROCK1 and functions as a tumor
suppressor in bladder cancer. J Cell Biochem. 121:4214–4225. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
188
|
Wu DD, Chen X, Sun KX, Wang LL, Chen S and
Zhao Y: Role of the lncRNA ABHD11-AS(1) in the tumorigenesis and
progression of epithelial ovarian cancer through targeted
regulation of RhoC. Mol Cancer. 16:1382017. View Article : Google Scholar : PubMed/NCBI
|
|
189
|
Wu Y, Zhao Y, Huan L, Zhao J, Zhou Y, Xu
L, Hu Z, Liu Y, Chen Z, Wang L, et al: An LTR
retrotransposon-derived long noncoding RNA lncMER52A promotes
hepatocellular carcinoma progression by binding p120-catenin.
Cancer Res. 80:976–987. 2020. View Article : Google Scholar
|
|
190
|
Shi D, Wu F, Mu S, Hu B, Zhong B, Gao F,
Qing X, Liu J, Zhang Z and Shao Z: LncRNA AFAP1-AS1 promotes
tumorigenesis and epithelial-mesenchymal transition of osteosarcoma
through RhoC/ROCK1/p38MAPK/Twist1 signaling pathway. J Exp Clin
Cancer Res. 38:3752019. View Article : Google Scholar : PubMed/NCBI
|
|
191
|
Huang Y, Hong W and Wei X: The molecular
mechanisms and therapeutic strategies of EMT in tumor progression
and metastasis. J Hematol Oncol. 15:1292022. View Article : Google Scholar : PubMed/NCBI
|
|
192
|
Kunc M, Skrzypkowska P, Pęksa R and
Biernat W: Tumor-to-tumor metastases: Systematic review and
meta-analysis of 685 reported cases. Clin Exp Metastasis.
42:142025. View Article : Google Scholar : PubMed/NCBI
|
|
193
|
Peng L, Wang D, Han Y, Huang T, He X, Wang
J and Ou C: Emerging role of cancer-associated fibroblasts-derived
exosomes in tumorigenesis. Front Immunol. 12:7953722021. View Article : Google Scholar
|
|
194
|
Zhang JY, Weng MZ, Song FB, Xu YG, Liu Q,
Wu JY, Qin J, Jin T and Xu J: Long noncoding RNA AFAP1-AS1
indicates a poor prognosis of hepatocellular carcinoma and promotes
cell proliferation and invasion via upregulation of the RhoA/Rac2
signaling. Int J Oncol. 48:1590–1598. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
195
|
Fan C, Tang Y, Wang J, Wang Y, Xiong F,
Zhang S, Li X, Xiang B, Wu X, Guo C, et al: Long non-coding RNA
LOC284454 promotes migration and invasion of nasopharyngeal
carcinoma via modulating the Rho/Rac signaling pathway.
Carcinogenesis. 40:380–391. 2019. View Article : Google Scholar
|
|
196
|
Hu Q, Lin X, Ding L, Zeng Y, Pang D,
Ouyang N, Xiang Y and Yao H: ARHGAP42 promotes cell migration and
invasion involving PI3K/Akt signaling pathway in nasopharyngeal
carcinoma. Cancer Med. 7:3862–3874. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
197
|
Fang G, Wang J, Sun X, Xu R, Zhao X, Shao
L, Sun C and Wang Y: LncRNA MAGI2-AS3 is downregulated in the
distant recurrence of hepatocellular carcinoma after surgical
resection and affects migration and invasion via ROCK2. Ann
Hepatol. 19:535–540. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
198
|
Liu F, Xiao Y, Ma L and Wang J: Regulating
of cell cycle progression by the lncRNA CDKN2B-AS1/miR-324-5p/ROCK1
axis in laryngeal squamous cell cancer. Int J Biol Markers.
35:47–56. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
199
|
Ma T, Ma H, Zou Z, He X, Liu Y, Shuai Y,
Xie M and Zhang Z: The long intergenic noncoding RNA 00707 promotes
lung adenocarcinoma cell proliferation and migration by regulating
Cdc42. Cell Physiol Biochem. 45:1566–1580. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
200
|
Song L, Wang L, Pan X and Yang C: lncRNA
OIP5-AS1 targets ROCK1 to promote cell proliferation and inhibit
cell apoptosis through a mechanism involving miR-143-3p in cervical
cancer. Braz J Med Biol Res. 53:e88832020. View Article : Google Scholar : PubMed/NCBI
|
|
201
|
Pan L, Meng Q, Li H, Liang K and Li B:
LINC00339 promotes cell proliferation, migration, and invasion of
ovarian cancer cells via miR-148a-3p/ROCK1 axes. Biomed
Pharmacother. 120:1094232019. View Article : Google Scholar : PubMed/NCBI
|
|
202
|
Chen S, Wang LL, Sun KX, Liu Y, Guan X,
Zong ZH and Zhao Y: LncRNA PCGEM1 induces ovarian carcinoma
tumorigenesis and progression through RhoA pathway. Cell Physiol
Biochem. 47:1578–1588. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
203
|
Yuan S, Luan X, Chen H, Shi X and Zhang X:
Long non-coding RNA EGFR-AS1 sponges micorRNA-381 to upregulate
ROCK2 in bladder cancer. Oncol Lett. 19:1899–1905. 2020.PubMed/NCBI
|
|
204
|
Shang W, Yang Y, Zhang J and Wu Q: Long
noncoding RNA BDNF-AS is a potential biomarker and regulates cancer
development in human retinoblastoma. Biochem Biophys Res Commun.
497:1142–1148. 2018. View Article : Google Scholar
|
|
205
|
Nikanjam M, Kato S and Kurzrock R: Liquid
biopsy: Current technology and clinical applications. J Hematol
Oncol. 15:1312022. View Article : Google Scholar : PubMed/NCBI
|
|
206
|
He X, Kuang G, Wu Y and Ou C: Emerging
roles of exosomal miRNAs in diabetes mellitus. Clin Transl Med.
11:e4682021. View Article : Google Scholar : PubMed/NCBI
|
|
207
|
Zhuang T, Wang S, Yu X, He X, Guo H and Ou
C: Current status and future perspectives of platelet-derived
extracellular vesicles in cancer diagnosis and treatment. Biomark
Res. 12:882024. View Article : Google Scholar : PubMed/NCBI
|
|
208
|
Wu S, Cui Y, Zhao H, Xiao X, Gong L, Xu H,
Zhou Q, Ma D and Li X: Trophoblast exosomal UCA1 induces
endothelial Injury through the PFN1-RhoA/ROCK pathway in
preeclampsia: A human-specific adaptive pathogenic mechanism. Oxid
Med Cell Longev. 2022:21989232022. View Article : Google Scholar : PubMed/NCBI
|
|
209
|
Ding AX, Wang H, Zhang JM, Yang W and
Kuang YT: lncRNA BANCR promotes the colorectal cancer metastasis
through accelerating exosomes-mediated M2 macrophage polarization
via regulating RhoA/ROCK signaling. Mol Cell Biochem. 479:13–27.
2024. View Article : Google Scholar
|
|
210
|
Horita K, Kurosaki H, Nakatake M, Kuwano
N, Oishi T, Itamochi H, Sato S, Kono H, Ito M, Hasegawa K, et al:
lncRNA UCA1-mediated Cdc42 signaling promotes oncolytic vaccinia
virus cell-to-cell spread in ovarian cancer. Mol Ther Oncolytics.
13:35–48. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
211
|
Liang L, Gu W, Li M, Gao R, Zhang X, Guo C
and Mi S: The long noncoding RNA HOTAIRM1 controlled by AML1
enhances glucocorticoid resistance by activating RHOA/ROCK1 pathway
through suppressing ARHGAP18. Cell Death Dis. 12:7022021.
View Article : Google Scholar : PubMed/NCBI
|
|
212
|
Xu K, Tian H, Zhao S, Yuan D, Jiang L, Liu
X, Zou B and Zhang J: Long noncoding RNA LOC441178 reduces the
invasion and migration of squamous carcinoma cells by targeting
ROCK1. Biomed Res Int. 2018:43576472018. View Article : Google Scholar : PubMed/NCBI
|
|
213
|
Zhang Z, Yu T and Geng W: Long non-coding
RNA CCHE1 participates in postoperative distant recurrence but not
local recurrence of osteosarcoma possibly by interacting with
ROCK1. BMC Musculoskelet Disord. 21:4622020. View Article : Google Scholar : PubMed/NCBI
|
|
214
|
Maldonado MDM and Dharmawardhane S:
Targeting Rac and Cdc42 GTPases in cancer. Cancer Res.
78:3101–3111. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
215
|
Guo X, Stafford LJ, Bryan B, Xia C, Ma W,
Wu X, Liu D, Songyang Z and Liu M: A Rac/Cdc42-specific exchange
factor, GEFT, induces cell proliferation, transformation, and
migration. J Biol Chem. 278:13207–13215. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
216
|
Hosseini K, Frenzel A and
Fischer-Friedrich E: EMT induces characteristic changes of Rho
GTPases and downstream effectors with a mitosis-specific twist.
Phys Biol. 20:2023. View Article : Google Scholar : PubMed/NCBI
|
|
217
|
Zhou W, Li X, Zhang B, Peng H, Quan C,
Xiao X, Luo M, Huang Y, Xu D, Huang K, et al: The long non-coding
RNA CCAT1 promotes erlotinib resistance in cholangiocarcinoma by
inducing epithelial-mesenchymal transition via the
miR-181a-5p/ROCK2 axis. Am J Cancer Res. 14:2852–2867. 2024.
View Article : Google Scholar : PubMed/NCBI
|
|
218
|
Abulwerdi FA, Xu W, Ageeli AA, Yonkunas
MJ, Arun G, Nam H, Schneekloth JS Jr, Dayie TK, Spector D, Baird N
and Le Grice SFJ: Selective small-molecule targeting of a triple
helix encoded by the long noncoding RNA, MALAT1. ACS Chem Biol.
14:223–235. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
219
|
Cruz-Collazo A, Ruiz-Calderon JF, Picon H,
Borrero-Garcia LD, Lopez I, Castillo-Pichardo L, Del Mar Maldonado
M, Duconge J, Medina JI, Bayro MJ, et al: Efficacy of Rac and Cdc42
inhibitor MBQ-167 in triple-negative breast cancer. Mol Cancer
Ther. 20:2420–2432. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
220
|
Moon GT, Lee JH, Jeong SH, Jin SW and Park
YM: NecroX-5 can suppress melanoma metastasis by reducing the
expression of Rho-family GTPases. J Clin Med. 10:27902021.
View Article : Google Scholar : PubMed/NCBI
|
|
221
|
Li D, Ding X, Xie M, Huang Z, Han P, Tian
D and Xia L: CAMSAP2-mediated noncentrosomal microtubule
acetylation drives hepatocellular carcinoma metastasis.
Theranostics. 10:3749–3766. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
222
|
Gastonguay A, Berg T, Hauser AD, Schuld N,
Lorimer E and Williams CL: The role of Rac1 in the regulation of
NF-κB activity, cell proliferation, and cell migration in non-small
cell lung carcinoma. Cancer Biol Ther. 13:647–656. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
223
|
Zhou M, He X, Zhang J, Mei C, Zhong B and
Ou C: tRNA-derived small RNAs in human cancers: Roles, mechanisms,
and clinical application. Mol Cancer. 23:762024. View Article : Google Scholar : PubMed/NCBI
|
|
224
|
Sarfi M, Abbastabar M and Khalili E: Long
noncoding RNAs biomarker-based cancer assessment. J Cell Physiol.
234:16971–16986. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
225
|
Mouraviev V, Lee B, Patel V, Albala D,
Johansen TE, Partin A, Ross A and Perera RJ: Clinical prospects of
long noncoding RNAs as novel biomarkers and therapeutic targets in
prostate cancer. Prostate Cancer Prostatic Dis. 19:14–20. 2016.
View Article : Google Scholar
|
|
226
|
Goyal B, Yadav SRM, Awasthee N, Gupta S,
Kunnumakkara AB and Gupta SC: Diagnostic, prognostic, and
therapeutic significance of long non-coding RNA MALAT1 in cancer.
Biochim Biophys Acta Rev Cancer. 1875:1885022021. View Article : Google Scholar : PubMed/NCBI
|
|
227
|
Alix-Panabières C and Pantel K: Liquid
biopsy: From discovery to clinical application. Cancer Discov.
11:858–873. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
228
|
Diez-Fraile A, Ceulaer J, Derpoorter C,
Spaas C, Backer T, Lamoral P, Abeloos J and Lammens T: Circulating
non-coding RNAs in head and neck cancer: Roles in diagnosis,
prognosis, and therapy monitoring. Cells. 10:482020. View Article : Google Scholar
|
|
229
|
Guo X, Peng Y, Song Q, Wei J, Wang X, Ru
Y, Xu S, Cheng X, Li X, Wu D, et al: A liquid biopsy signature for
the early detection of gastric cancer in patients.
Gastroenterology. 165:402–413. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
230
|
Raza A, Khan AQ, Inchakalody VP, Mestiri
S, Yoosuf ZSKM, Bedhiafi T, El-Ella DMA, Taib N, Hydrose S, Akbar
S, et al: Dynamic liquid biopsy components as predictive and
prognostic biomarkers in colorectal cancer. J Exp Clin Cancer Res.
41:992022. View Article : Google Scholar : PubMed/NCBI
|
|
231
|
Kabzinski J, Kucharska-Lusina A and
Majsterek I: RNA-based liquid biopsy in head and neck cancer.
Cells. 12:19162023. View Article : Google Scholar : PubMed/NCBI
|
|
232
|
Zhang N, Zhang H, Wu W, Zhou R, Li S, Wang
Z, Dai Z, Zhang L, Liu F, Liu Z, et al: Machine learning-based
identification of tumor-infiltrating immune cell-associated lncRNAs
for improving outcomes and immunotherapy responses in patients with
low-grade glioma. Theranostics. 12:5931–5948. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
233
|
Lu Q, Li J, Chen W, Wang Z, Wang D, Liu C,
Sun Y, Jiang H, Zhang C, Chang Y, et al: NetLnc: A network-based
computational framework to identify immune checkpoint-related
lncRNAs for Immunotherapy response in melanoma. Int J Mol Sci.
26:45572025. View Article : Google Scholar : PubMed/NCBI
|
|
234
|
Liu Y, Chen J, Yang D, Liu C, Tang C, Cai
S and Huang Y: Machine learning combined with multi-omics to
identify immune-related LncRNA signature as biomarkers for
predicting breast cancer prognosis. Sci Rep. 15:238632025.
View Article : Google Scholar : PubMed/NCBI
|
|
235
|
Zhu Y, Zhu L, Wang X and Jin H: RNA-based
therapeutics: An overview and prospectus. Cell Death Dis.
13:6442022. View Article : Google Scholar : PubMed/NCBI
|
|
236
|
Puri B, Majumder S and Gaikwad AB: LncRNA
MALAT1 as a potential diagnostic and therapeutic target in kidney
diseases. Pathol Res Pract. 266:1557832025. View Article : Google Scholar
|
|
237
|
Chen Y, Li Z, Chen X and Zhang S: Long
non-coding RNAs: From disease code to drug role. Acta Pharm Sin B.
11:340–354. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
238
|
Botti G, Marra L, Malzone MG, Anniciello
A, Botti C, Franco R and Cantile M: LncRNA HOTAIR as prognostic
circulating Marker and potential therapeutic target in patients
with tumor diseases. Curr Drug Targets. 18:27–34. 2017. View Article : Google Scholar
|
|
239
|
Prabhakaran R, Thamarai R, Sivasamy S,
Dhandayuthapani S, Batra J, Kamaraj C, Karthik K, Shah MA and
Mallik S: Epigenetic frontiers: miRNAs, long non-coding RNAs and
nanomaterials are pioneering to cancer therapy. Epigenetics
Chromatin. 17:312024. View Article : Google Scholar : PubMed/NCBI
|
|
240
|
Yang L, Li Z, Huang X, Huang L, Fu Y, Zhao
B, Zhang Y, Ma L, Jing S, Fu L, et al: VPS9D1-AS1 antisense therapy
via lipid nanoparticles reprograms cold tumors and enhances
immunotherapy in colorectal cancer. J Control Release.
384:1138652025. View Article : Google Scholar : PubMed/NCBI
|
|
241
|
He X, Lin F, Jia R, Xia Y, Liang Z, Xiao
X, Hu Q, Deng X, Li Q and Sheng W: Coordinated modulation of long
non-coding RNA ASBEL and curcumin co-delivery through
multicomponent nanocomplexes for synchronous triple-negative breast
cancer theranostics. J Nanobiotechnology. 21:3972023. View Article : Google Scholar : PubMed/NCBI
|
|
242
|
Jia F, Li Y, Deng X, Wang X, Cui X, Lu J,
Pan Z and Wu Y: Self-assembled fluorescent hybrid
nanoparticles-mediated collaborative lncRNA CCAT1 silencing and
curcumin delivery for synchronous colorectal cancer theranostics. J
Nanobiotechnology. 19:2382021. View Article : Google Scholar : PubMed/NCBI
|
|
243
|
Zhang Y, Liu F, Tan L, Li X, Dai Z, Cheng
Q, Liu J, Wang Y, Huang L, Wang L and Wang Z: LncRNA-edited
biomimetic nanovaccines combined with anti-TIM-3 for augmented
immune checkpoint blockade immunotherapy. J Control Release.
361:671–680. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
244
|
Herman AB, Tsitsipatis D and Gorospe M:
Integrated lncRNA function upon genomic and epigenomic regulation.
Mol Cell. 82:2252–2266. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
245
|
Yip CW, Sivaraman DM, Prabhu AV and Shin
JW: Functional annotation of lncRNA in high-throughput screening.
Essays Biochem. 65:761–773. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
246
|
Street CA and Bryan BA: Rho kinase
proteins-pleiotropic modulators of cell survival and apoptosis.
Anticancer Res. 31:3645–3657. 2011.PubMed/NCBI
|
|
247
|
Street CA, Routhier AA, Spencer C, Perkins
AL, Masterjohn K, Hackathorn A, Montalvo J, Dennstedt EA and Bryan
BA: Pharmacological inhibition of Rho-kinase (ROCK) signaling
enhances cisplatin resistance in neuroblastoma cells. Int J Oncol.
37:1297–1305. 2010.PubMed/NCBI
|
